Eli Lilly has announced that it will be acquiring Loxo Oncology for around $8 billion in cash, or an offer of $235 a share. The offer is roughly 68% higher than Loxo’s closing price this past Friday. Shares of the company were soaring nearly 70% while shares of Lilly dropped 1.5%. “We’d like to grow … Continue reading “Eli Lilly to Acquire Loxo Oncology for $8 Billion”
